Aller au contenu principal
English
Formulaire de recherche
Rechercher
Suivez l'Institut:
Contactez-nous
A propos de nous
Donate
D’accueil
Recherche
Liberté économique
Performance des Écoles
Votre Soutien
Who was Barbara Mitchell?
Access to Drugs
Access to Drugs
Access to Drugs
Janvier 19, 2018
1:56PM
Ottawa’s revisions to drug-pricing review board will delay or prevent access to new drugs
Dr. Nigel Rawson
Pharmaceutical manufacturers take on a significant investment risk to develop new drugs.
Étiquettes:
drug costs
,
prescription drug costs
,
Access to Drugs
,
patented drugs